Company intelligence / Profile preview
CryptoMedix
Harpswell, Maine, United Statescryptomedix.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
CryptoMedix is a private U.S. oncology-focused biotechnology company developing immuno-oncology therapeutics that target the tumor microenvironment. The company describes its lead approach as first-in-class therapeutic antibodies designed to enhance cytotoxic T-cell migration and function while reducing tumor-supportive macrophage activity in tumors. Its disclosed programs include CMX-101 and CMX-102, with CMX-102 also described as potentially suitable for antibody-drug conjugate or radionuclide-conjugate applications. Company materials and third-party profiles indicate an early-stage, preclinical pipeline and an active search for funding and strategic partnerships to advance development.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Monoclonal antibodyAntibody-drug conjugateRadiopharmaceutical
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on CryptoMedix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CryptoMedix.